Inventor · disambiguated record
Melanie Marota
Also filed as: MAROTA MELANIE · MAROTA MELANIE J
7 granted patents·7 pending applications·40 citations·filing 2015–2025
84Inventor score
Top patents by PatentIndex Score
14 records- 0196US12220408B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Feb 11, 2025·5 cites·30 claims
- 0296US12168004B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Dec 17, 2024·5 cites·30 claims
- 0396US11925709B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2020·Granted Mar 12, 2024·12 cites·10 claims
- 0495US12310953B2Pharmaceutical formulations for the treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted May 27, 2025·3 cites·30 claims
- 0592US10117836B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 6, 2018·15 cites·21 claims
- 0688US2025064788A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 0779US2023248655A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2023·Application pending·0 cites
- 0878US12458633B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·32 claims
- 0977US12458632B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·29 claims
- 1059US2019209478A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1157US2024238367A1Compounds for treating conditions related to pcsk9 activityMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1238US2016346198A1Novel disintegration systems for pharmaceutical dosage formsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 1330US2016339074A1Pharmaceutical composition of selective hcv ns3/4a inhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 1430US2018228828A1Fixed-dose combinations of antiviral compoundsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →